Home Journal Club FAQ My Amedeo About Tranquillis Services Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Liver Diseases

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 54 articles:
HTML format
Text format



Single Articles


    March 2010
  1. SHI YH , Ding ZB, Fan J
    Reply to Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma.
    Cancer. 2010.
    PubMed     Text format     Related articles   


  2. TAKAMURA M , Aoyagi Y
    Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma.
    Cancer. 2010.
    PubMed     Text format     Related articles   


    February 2010
  3. HASSAN MM , Curley SA, Li D, Kaseb A, et al
    Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available


  4. YU JC , Neugut AI, Wang S, Jacobson JS, et al
    Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available


  5. SIMONS JP , Ng SC, Hill JS, Shah SA, et al
    In-hospital mortality from liver resection for hepatocellular carcinoma: a simple risk score.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available


    January 2010
  6. HUYNH H
    AZD6244 (ARRY-142886) enhances the antitumor activity of rapamycin in mouse models of human hepatocellular carcinoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available


  7. ARTINYAN A , Mailey B, Sanchez-Luege N, Khalili J, et al
    Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available


  8. CARR BI , Kondragunta V, Buch SC, Branch RA, et al
    Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a Two-Cohort Study.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available


    December 2009
  9. LADAS EJ , Kroll DJ, Oberlies NH, Cheng B, et al
    A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL).
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


  10. DE HAAS RJ , Wicherts DA, Salloum C, Andreani P, et al
    Long-term outcomes after hepatic resection for colorectal metastases in young patients.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


    November 2009
  11. IWAMOTO S , Yamaguchi T, Hongo O, Iwamoto H, et al
    Excellent outcomes with angiographic subsegmentectomy in the treatment of typical hepatocellular carcinoma: a retrospective study of local recurrence and long-term survival rates in 120 patients with hepatocellular carcinoma.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


  12. KEIZMAN D , Maimon N, Ish-Shalom M, Buchbut D, et al
    An animal model for chemotherapy-associated steatohepatitis and its prevention by the oral administration of fatty acid bile acid conjugate.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


    October 2009
  13. SIEGEL AB , Zhu AX
    Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


  14. SULLIVAN MJ
    Hepatoblastoma, cisplatin, and ototoxicity: good news on deaf ears.
    Cancer. 2009.
    PubMed     Text format     Related articles   


  15. KATZENSTEIN HM , Chang KW, Krailo M, Chen Z, et al
    Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


    August 2009
  16. MENG Z , Yang P, Shen Y, Bei W, et al
    Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


  17. YAU T , Yao TJ, Chan P, Epstein RJ, et al
    The outcomes of elderly patients with hepatocellular carcinoma treated with transarterial chemoembolization.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


  18. YU Y , Lang Q, Chen Z, Li B, et al
    The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


  19. WU TT , Levy M, Correa AM, Rosen CB, et al
    Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


    July 2009
  20. NAKAYAMA H , Sugahara S, Tokita M, Fukuda K, et al
    Proton beam therapy for hepatocellular carcinoma: the University of Tsukuba experience.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


  21. MCINTOSH A , Hagspiel KD, Al-Osaimi AM, Northup P, et al
    Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


  22. THORNTON RH , Covey A, Petre EN, Riedel ER, et al
    A comparison of outcomes from treating hepatocellular carcinoma by hepatic artery embolization in patients younger or older than 70 years.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


  23. BOUCHAHDA M , Adam R, Giacchetti S, Castaing D, et al
    Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


  24. KASEB AO , Hanbali A, Cotant M, Hassan MM, et al
    Vascular endothelial growth factor in the management of hepatocellular carcinoma: a review of literature.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


  25. DING ZB , Shi YH, Zhou J, Shi GM, et al
    Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


    June 2009
  26. WANG XM , Yang LY, Guo L, Fan C, et al
    p53-Induced ring-H2 protein, a novel marker for poor survival in hepatocellular carcinoma after hepatic resection.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


  27. XU MZ , Yao TJ, Lee NP, Ng IO, et al
    Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


  28. BRACONI C , Meng F, Swenson E, Khrapenko L, et al
    Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


  29. VARBAN O , Levine EA, Stewart JH, McCoy TP, et al
    Outcomes associated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in colorectal cancer patients with peritoneal surface disease and hepatic metastases.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


  30. ISHIZAWA T , Fukushima N, Shibahara J, Masuda K, et al
    Real-time identification of liver cancers by using indocyanine green fluorescent imaging.
    Cancer. 2009;115:2491-504.
    PubMed     Text format     Related articles    Abstract available


    May 2009
  31. SAPHNER T , Triest-Robertson S, Li H, Holzman P, et al
    The association of nonalcoholic steatohepatitis and tamoxifen in patients with breast cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


  32. VAN BUREN G 2ND , Gray MJ, Dallas NA, Xia L, et al
    Targeting the urokinase plasminogen activator receptor with a monoclonal antibody impairs the growth of human colorectal cancer in the liver.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


    April 2009
  33. HE J , Zeng ZC, Tang ZY, Fan J, et al
    Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


    March 2009
  34. MULCAHY MF , Lewandowski RJ, Ibrahim SM, Sato KT, et al
    Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


  35. WHELER J , Tsimberidou AM, Hong D, Naing A, et al
    Survival of patients in a Phase 1 Clinic: the M. D. Anderson Cancer Center experience.
    Cancer. 2009;115:1091-9.
    PubMed     Text format     Related articles    Abstract available


    February 2009
  36. YIN XY , Xie XY, Lu MD, Xu HX, et al
    Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


  37. VAUTHEY JN , Zorzi D
    The patient behind the code, the care behind the patient.
    Cancer. 2009;115:702-3.
    PubMed     Text format     Related articles   


    January 2009
  38. ZHANG XB , Wang JH, Yan ZP, Qian S, et al
    Hepatocellular carcinoma with main portal vein tumor thrombus: treatment with 3-dimensional conformal radiotherapy after portal vein stenting and transarterial chemoembolization.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


  39. ROBERTSON DJ , Stukel TA, Gottlieb DJ, Sutherland JM, et al
    Survival after hepatic resection of colorectal cancer metastases: a national experience.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


  40. SCHOOTMAN M , Jeffe DB, Gillanders WE, Aft R, et al
    Racial disparities in the development of breast cancer metastases among older women: a multilevel study.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


    December 2008
  41. KOBAYASHI M , Ikeda K, Kawamura Y, Yatsuji H, et al
    High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available


  42. FORNER A , Ayuso C, Varela M, Rimola J, et al
    Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available


  43. YAU T , Chan P, Ng KK, Chok SH, et al
    Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: presence of lung metastasis predicts poor response.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available


    October 2008
  44. YAU T , Yao TJ, Chan P, Ng K, et al
    A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy: implication for patient selection in systemic therapy trials.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available


  45. TANABE KK
    The past 60 years in liver surgery.
    Cancer. 2008;113.
    PubMed     Text format     Related articles    Abstract available


    September 2008
  46. ADDEO R , De Rosa C, Faiola V, Leo L, et al
    Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available


  47. ROBBINS AS , Daily MF, Aoki CA, Chen MS Jr, et al
    Decreasing disparity in liver transplantation among white and Asian patients with hepatocellular carcinoma: California, 1998-2005.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available


  48. KING J , Quinn R, Glenn DM, Janssen J, et al
    Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases.
    Cancer. 2008;113:921-9.
    PubMed     Text format     Related articles    Abstract available


  49. JIM MA , Perdue DG, Richardson LC, Espey DK, et al
    Primary liver cancer incidence among American Indians and Alaska Natives, US, 1999-2004.
    Cancer. 2008;113.
    PubMed     Text format     Related articles    Abstract available


    August 2008
  50. KIM JH , Yoon HK, Sung KB, Ko GY, et al
    Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma : clinical efficacy and factors influencing outcomes.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available


    July 2008
  51. LEONG SS , Wee J, Rajan S, Toh CK, et al
    Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma.
    Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available


  52. HAUSCHILD A , Dummer R, Ugurel S, Kaehler KC, et al
    Combined treatment with pegylated interferon-alpha-2a and dacarbazine in patients with advanced metastatic melanoma: a phase 2 study.
    Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available


    June 2008
  53. AKCAKANAT A , Sahin A, Shaye AN, Velasco MA, et al
    Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastases.
    Cancer. 2008;112:2352-8.
    PubMed     Text format     Related articles    Abstract available


    April 2008
  54. WESTON BR , Ross WA, Wolff RA, Evans D, et al
    Rate of bilirubin regression after stenting in malignant biliary obstruction for the initiation of chemotherapy: how soon should we repeat endoscopic retrograde cholangiopancreatography?
    Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: